Statutory Committee inquiries
The Statutory Committee will meet at the Royal Pharmaceutical Society of Great
Britain, 1 Lambeth High Street, London SE1, at 9.30am on Monday 21 February,
Tuesday 22 February, Wednesday 23 February and Thursday 24 February 2005 to
hear the following inquiries:
Monday 21 February
1. An inquiry into a complaint by the Council of the Society against a pharmacist
which alleges that the dispensing of excessive doses of diamorphine against
prescriptions written by a GP, the failure to maintain appropriate stocks
of diamorphine in lower dosages, the failure to exercise sufficient scrutiny
of prescriptions for excessive doses of diamorphine, the failure to exercise
sufficient control over the product supplied, the failure to exercise the
professional judgement and/or the objectivity of a reasonably careful and
competent pharmacist, the failure to act towards the GP in a way that was
to the benefit and welfare of the public and patients and the failure to
discharge obligations as a pharmacist to patients may amount to misconduct.
Tuesday 22 February
2. The committee will continue its inquiry from Monday 21 February referred
to in paragraph 1 above.
Wednesday 23 February
3. The committee will resume its inquiry from 25 February 2004 into the case
of a pharmacist which alleges that altering the quantity of a medicine prescribed
for the pharmacist on two prescriptions, thereby procuring a greater quantity
of the medicine than had been authorised by the general practitioner, may
amount to misconduct.
Thursday 24 February
4. The committee will resume its inquiry from 21 July 2004 into a complaint
by the Council of the Society against a pharmacist which alleges that the
application of a system which resulted in overpayment to the pharmacist by
the Prescription Pricing Authority (on behalf of the Department of Health)
and the supply of chlormethiazole capsules to a patient without the authority
of a prescription may amount to misconduct.
5. The committee will resume its inquiry from 26 January 2005 into the case
of a pharmacist and a company which alleges that the submission of erroneous
claims to the PPA resulting in an overpayment of approximately £52,000
may amount to misconduct.
6. The Committee will resume its inquiry into a complaint by the Council of
the Society against a pharmacist which includes allegations that the consumption
of alcohol while in charge of the pharmacy and being on duty when unfit to
be in charge of the pharmacy, may amount to misconduct.
7. The committee will resume its inquiry into a complaint by the Council of
the Society against a pharmacist which includes allegations that the theft
of prescription-only medicines from the pharmacy, in respect of which the pharmacist
received an adult caution from the police, and the self-administration of prescription-only
medicines from pharmacy stock may amount to misconduct.
David Gomez
Secretary to the Statutory Committee |
The
Pharmaceutical Journal